MPO and viral infectious disease: On the treatment of viral infections, Yamamoto et al., 1991, show already at that time that the influenza virus IFV was inactivated by MPO-myeloperoxidase treatment of human polymorphonuclear leukocytes in the presence of H2O2 and that viral protein modification occurred in all major proteins, including the inner envelope proteins [161].